Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Early-stage skin substitutes improve wound healing and skin structure.

Topical Valproate is safe for human skin and unlikely to cause irritation.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Microfluidic models improve testing for aging, wound healing, and oral tissue, reducing animal testing.

Two siblings were diagnosed with Trichothiodystrophy, identified by brittle hair and low sulfur content.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

The new formulation improved the skin absorption of the drug Thiocolchicoside.

The US and EU lead in cell and gene therapy regulations with more approvals and clinical trials, while India is in early stages with fewer approvals and expedited processes.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

The document concludes that more research is needed to confirm if blood tests for things like iron and vitamin D are helpful for hair loss from Telogen effluvium.

The DiLiCre mouse model is an effective tool for precise genome editing using light.

Transethosomes improve drug delivery through the skin and show promise for treating various conditions.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Vitamin D deficiency is common in temporary hair loss, and stress is often a suspected cause.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Telogen effluvium causes temporary hair loss, but new hair still grows.

Two sisters had a rare hair condition without other usual symptoms.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Entadfi, a mix of finasteride and tadalafil, is used for BPH.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Activating TERT in mice skin boosts hair growth by waking up hair follicle stem cells.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Topical tofacitinib shows promise as a future treatment for alopecia areata.